10,000 Shares in Tempus AI, Inc. (NASDAQ:TEM) Purchased by United Capital Management of KS Inc.

Key Points

• United Capital Management of KS Inc. invested approximately $482,000 in Tempus AI, purchasing 10,000 shares during the 1st quarter of the year.
• Tempus AI reports a quarterly revenue increase of 89.5% year-over-year, with earnings per share of $(0.22) beating expectations.
• Insider trading activity shows significant sales by executives, including a director selling over 205,000 shares, indicating a decrease in their holdings.

United Capital Management of KS Inc. acquired a new position in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 10,000 shares of the company's stock, valued at approximately $482,000.

A number of other institutional investors have also made changes to their positions in TEM. Aberdeen Group plc grew its stake in Tempus AI by 209.0% in the first quarter. Aberdeen Group plc now owns 254,730 shares of the company's stock valued at $12,288,000 after acquiring an additional 172,280 shares during the period. Trivium Point Advisory LLC acquired a new position in Tempus AI in the first quarter valued at about $242,000. Vestmark Advisory Solutions Inc. grew its stake in Tempus AI by 36.4% in the first quarter. Vestmark Advisory Solutions Inc. now owns 166,998 shares of the company's stock valued at $8,056,000 after acquiring an additional 44,548 shares during the period. Tokio Marine Asset Management Co. Ltd. acquired a new position in Tempus AI in the first quarter valued at about $348,000. Finally, Caitong International Asset Management Co. Ltd grew its stake in Tempus AI by 27,717.6% in the first quarter. Caitong International Asset Management Co. Ltd now owns 14,187 shares of the company's stock valued at $684,000 after acquiring an additional 14,136 shares during the period. 24.22% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on TEM shares. BTIG Research started coverage on Tempus AI in a research note on Friday, August 8th. They issued a "buy" rating and a $60.00 target price for the company. Guggenheim boosted their target price on Tempus AI from $65.00 to $75.00 and gave the company a "buy" rating in a research note on Monday, June 30th. Needham & Company LLC reissued a "buy" rating and issued a $70.00 target price on shares of Tempus AI in a research note on Friday, August 8th. Bank of America boosted their price target on Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a report on Wednesday, June 25th. Finally, Morgan Stanley boosted their price target on Tempus AI from $65.00 to $68.00 and gave the company an "overweight" rating in a report on Tuesday, August 12th. Six equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $65.36.

Insider Buying and Selling

In other Tempus AI news, Director Jennifer A. Doudna sold 625 shares of the firm's stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $62.52, for a total transaction of $39,075.00. Following the completion of the transaction, the director directly owned 26,554 shares in the company, valued at approximately $1,660,156.08. This trade represents a 2.30% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Erik Phelps sold 51,317 shares of Tempus AI stock in a transaction dated Monday, June 16th. The stock was sold at an average price of $72.56, for a total transaction of $3,723,561.52. Following the sale, the executive vice president owned 97,779 shares of the company's stock, valued at approximately $7,094,844.24. This trade represents a 34.42% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 802,772 shares of company stock worth $54,080,775. 27.60% of the stock is currently owned by insiders.

Tempus AI Stock Performance

Shares of NASDAQ:TEM traded up $2.19 on Friday, hitting $73.78. 14,646,490 shares of the company were exchanged, compared to its average volume of 10,221,011. The firm has a market capitalization of $12.77 billion, a P/E ratio of -62.00 and a beta of 4.98. The stock's 50 day moving average price is $63.13 and its 200 day moving average price is $58.63. Tempus AI, Inc. has a 1-year low of $31.36 and a 1-year high of $91.45. The company has a current ratio of 1.54, a quick ratio of 1.56 and a debt-to-equity ratio of 2.58.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its quarterly earnings results on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, topping analysts' consensus estimates of ($0.23) by $0.01. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. The firm had revenue of $314.64 million for the quarter, compared to analyst estimates of $296.84 million. During the same period in the previous year, the business posted ($6.86) earnings per share. Tempus AI's quarterly revenue was up 89.5% on a year-over-year basis. Sell-side analysts predict that Tempus AI, Inc. will post -6.15 EPS for the current year.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.